# Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome

> **NCT00316550** · PHASE1 · TERMINATED · sponsor: **Avera Pharmaceuticals** · enrollment: 24 (estimated)

## Conditions studied

- Irritable Bowel Syndrome (IBS)

## Interventions

- **DRUG:** AV608

## Key facts

- **NCT ID:** NCT00316550
- **Lead sponsor:** Avera Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-04
- **Primary completion:** 2007-06
- **Final completion:** 2007-09
- **Target enrollment:** 24 (ESTIMATED)
- **Why stopped:** Animal Safety Data
- **Last updated:** 2008-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00316550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00316550, "Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00316550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*